Allarity Therapeutics, Inc. APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition
Allarity Therapeutics, Inc. (ALLR) reported APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition of $22.00 thousand for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-05.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition · last filed 2024-08-05
- Allarity Therapeutics, Inc. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2024-06-30 was $22.00K, a 87.78% decline year-over-year.
- Allarity Therapeutics, Inc. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2024-03-31 was -$32.00K.
- Allarity Therapeutics, Inc. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2023-06-30 was $180.00K.
- Allarity Therapeutics, Inc. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2023-03-31 was -$121.00K.
- Allarity Therapeutics, Inc. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2023 was $71.00K, a 95.95% decline from fiscal 2022.
- Allarity Therapeutics, Inc. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2022 was $1.75M.
| Period end | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 12 month |
|---|---|---|---|
| 2024-06-30 | $22.00K 10-Q · filed 2024-08-05 | -$10.00K derived: sum of 2 quarters · filed 2024-08-05 | |
| 2024-03-31 | -$32.00K 10-Q · filed 2024-08-05 | ||
| 2023-12-31 | $71.00K 10-K · filed 2024-03-08 | ||
| 2023-06-30 | $180.00K 10-Q · filed 2024-08-05 | $59.00K derived: sum of 2 quarters · filed 2024-08-05 | |
| 2023-03-31 | -$121.00K 10-Q · filed 2024-08-05 | ||
| 2022-12-31 | $1.75M 10-K · filed 2024-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |